Patents by Inventor Kenneth Wilson

Kenneth Wilson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210347018
    Abstract: The subject matter described in this specification relates generally to a tool for installing a flexible metal conduit screw-in connector onto a flexible metal conduit and a method for installing the flexible metal conduit connector tool. The flexible metal conduit screw-in connector tool includes a handle, a centering rod, and two studs. The flexible metal conduit connector tool is to engage a flexible metal conduit screw-in connector.
    Type: Application
    Filed: May 7, 2020
    Publication date: November 11, 2021
    Inventor: Kenneth Wilson Huffines
  • Patent number: 11038030
    Abstract: A Field Effect Transistor (FET) having a source, drain, and gate disposed laterally along a surface of a semiconductor and a field plate structure: having one end connected to the source; and having a second end disposed between the gate and the drain and separated from the drain by a gap. A dielectric structure is disposed over the semiconductor, having: a first portion disposed under the second end of the field plate structure; and, a second, thinner portion under the gap.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: June 15, 2021
    Assignee: Raytheon Company
    Inventors: Christopher J. MacDonald, Kenneth A. Wilson, Kamal Tabatabaie Alavi, Adrian D. Williams
  • Publication number: 20210037832
    Abstract: A delivery method for bacteria, viruses, fungi and dsRNA in which the bacteria, virus, fungus or dsRNA is protected from degradation by UV light by encapsulation in a particle of wax also containing a UV blocker. The formulation may also include other chemistry, such as insecticides. The particles are edible by insects and their larva and result in ingestion of the bacteria, virus, fungi and/or dsRNA by the insect or larva, resulting in control thereof.
    Type: Application
    Filed: March 1, 2019
    Publication date: February 11, 2021
    Applicant: Terramera Exco Holdings Ltd.
    Inventors: Igor CURCIC, Martin BROWN, David GRZYWACZ, Kenneth WILSON
  • Publication number: 20210015106
    Abstract: Composite particles comprising baculovirus particles in a coating of wax that is degradable in the gut of a larva of an arthropod species, optionally in conjunction with an insecticide, methods of manufacture, uses thereof, and methods of controlling arthropod infestations.
    Type: Application
    Filed: October 5, 2020
    Publication date: January 21, 2021
    Inventors: Igor CURCIC, Martin BROWN, David GRZYWACZ, Kenneth WILSON
  • Patent number: 10813358
    Abstract: Composite particles comprising baculovirus particles in a coating of wax that is degradable in the gut of a larva of an arthropod species, optionally in conjunction with an insecticide, methods of manufacture, uses thereof, and methods of controlling arthropod infestations.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: October 27, 2020
    Assignee: Terramera Exco Holdings Ltd.
    Inventors: Igor Curcic, Martin Brown, David Grzywacz, Kenneth Wilson
  • Publication number: 20200243652
    Abstract: A Field Effect Transistor (FET) having a source, drain, and gate disposed laterally along a surface of a semiconductor and a field plate structure: having one end connected to the source; and having a second end disposed between the gate and the drain and separated from the drain by a gap. A dielectric structure is disposed over the semiconductor, having: a first portion disposed under the second end of the field plate structure; and, a second, thinner portion under the gap.
    Type: Application
    Filed: April 13, 2020
    Publication date: July 30, 2020
    Applicant: Raytheon Company
    Inventors: Christopher J. MacDonald, Kenneth A. Wilson, Kamal Tabatabaie Alavi, Adrian D. Williams
  • Patent number: 10720497
    Abstract: A Field Effect Transistor (FET) having a source, drain, and gate disposed laterally along a surface of a semiconductor and a field plate structure: having one end connected to the source; and having a second end disposed between the gate and the drain and separated from the drain by a gap. A dielectric structure is disposed over the semiconductor, having: a first portion disposed under the second end of the field plate structure; and, a second, thinner portion under the gap.
    Type: Grant
    Filed: October 24, 2017
    Date of Patent: July 21, 2020
    Assignee: Raytheon Company
    Inventors: Christopher J. MacDonald, Kenneth A. Wilson, Kamal Tabatabaie Alavi, Adrian D. Williams
  • Publication number: 20190123150
    Abstract: A Field Effect Transistor (FET) having a source, drain, and gate disposed laterally along a surface of a semiconductor and a field plate structure: having one end connected to the source; and having a second end disposed between the gate and the drain and separated from the drain by a gap. A dielectric structure is disposed over the semiconductor, having: a first portion disposed under the second end of the field plate structure; and, a second, thinner portion under the gap.
    Type: Application
    Filed: October 24, 2017
    Publication date: April 25, 2019
    Applicant: Raytheon Company
    Inventors: Christopher J. MacDonald, Kenneth A. Wilson, Kamal Tabatabaie Alavi, Adrian D. Williams
  • Publication number: 20180206503
    Abstract: Composite particles comprising baculovirus particles in a coating of wax that is degradable in the gut of a larva of an arthropod species, optionally in conjunction with an insecticide, methods of manufacture, uses thereof, and methods of controlling arthropod infestations.
    Type: Application
    Filed: July 28, 2016
    Publication date: July 26, 2018
    Applicant: Exosect Limited
    Inventors: Igor CURCIC, Martin BROWN, David GRZYWACZ, Kenneth WILSON
  • Patent number: 9958888
    Abstract: In one embodiment, an apparatus includes a controller to control a voltage regulator. The controller may have a first comparator circuit to compare a first reference voltage to a feedback voltage. In turn, the first comparator circuit may include: a first comparator having a first input terminal to receive the feedback voltage and a second input terminal to receive the reference voltage and an output node to output an error signal based on the comparison; and a first pre-charge circuit coupled between the first input terminal and the output node configured to pre-charge a first portion of a compensation network to a pre-charge level. The first controller may further include a second comparator circuit coupled to the first comparator circuit compare the error signal to a ramp signal and to generate a first control output to control a power train of the voltage regulator in a first mode of operation.
    Type: Grant
    Filed: June 16, 2015
    Date of Patent: May 1, 2018
    Assignee: Silicon Laboratories Inc.
    Inventors: Dazhi Wei, Gang Yuan, Erik Pankratz, Imranul Islam, Praveen Kallam, Axel Thomsen, Kenneth Wilson Fernald, Jinwen Xiao
  • Patent number: 9792705
    Abstract: An atlas application enables an electronic display device to receive touch input from a user on a screen of the display device to access an atlas database to obtain graphic map information representative of a portion of the surface of the earth and to display the obtained graphic map information on the screen of the display as a graphic map showing a plurality of points of interest on the portion of the surface of the earth. The user is able to manipulate the graphic map by touch to locate and select a particular point of interest for detailed examination. The atlas data may contain at least one of descriptive textual information and graphic map information representative of particular points of interest selected by the user. A position of the device may be selected or determined to assist in presenting various points of interest for perusal.
    Type: Grant
    Filed: September 14, 2016
    Date of Patent: October 17, 2017
    Assignee: Flight Plan LLC
    Inventor: Kenneth Wilson
  • Patent number: 9688554
    Abstract: In some embodiments, a wastewater treatment system may reduce contaminants in water. A system may include one or more bioreactors which include a substrate that supports a biofilm. The bacteria used to form the biofilm may be selected to maximize the reduction of contaminants in water. Various components of the wastewater treatment system may be optimized to improve the efficiency and energy consumption of the wastewater system.
    Type: Grant
    Filed: October 31, 2014
    Date of Patent: June 27, 2017
    Assignee: Sam Houston State University
    Inventors: R. Gavin Jones, Kenneth Wilson, Sabin Holland, Michael D. Rainone
  • Publication number: 20160370816
    Abstract: In one embodiment, an apparatus includes a controller to control a voltage regulator. The controller may have a first comparator circuit to compare a first reference voltage to a feedback voltage. In turn, the first comparator circuit may include: a first comparator having a first input terminal to receive the feedback voltage and a second input terminal to receive the reference voltage and an output node to output an error signal based on the comparison; and a first pre-charge circuit coupled between the first input terminal and the output node configured to pre-charge a first portion of a compensation network to a pre-charge level. The first controller may further include a second comparator circuit coupled to the first comparator circuit compare the error signal to a ramp signal and to generate a first control output to control a power train of the voltage regulator in a first mode of operation.
    Type: Application
    Filed: June 16, 2015
    Publication date: December 22, 2016
    Inventors: Dazhi Wei, Gang Yuan, Erik Pankratz, Imranul Islam, Praveen Kallam, Axel Thomsen, Kenneth Wilson Fernald, Jinwen Xiao
  • Patent number: 9484609
    Abstract: A transmission line structure having a pair of separated coplanar waveguide transmissions line section. A coupling circuit is coupled between the pair of coplanar waveguide transmissions line sections, the coupling circuit suppresses common mode signals therein and passes, substantially unsuppressed, differential mode signal transmission between the pair of coplanar waveguide transmissions line sections.
    Type: Grant
    Filed: March 4, 2014
    Date of Patent: November 1, 2016
    Assignee: RAYTHEON COMPANY
    Inventors: Shahed Reza, Michael F. Parkes, Kenneth A. Wilson
  • Patent number: 9476731
    Abstract: An atlas application enables an electronic display device to receive touch input from a user on a screen of the display device to access an atlas database to obtain graphic map information representative of a portion of the surface of the earth and to display the obtained graphic map information on the screen of the display as a graphic map showing a plurality of points of interest on the portion of the surface of the earth. The user is able to manipulate the graphic map by touch to locate and select a particular point of interest for detailed examination. The atlas data may contain at least one of descriptive textual information and graphic map information representative of particular points of interest selected by the user. A position of the device may be selected or determined to assist in presenting various points of interest for perusal.
    Type: Grant
    Filed: January 13, 2015
    Date of Patent: October 25, 2016
    Assignee: Flight Plan LLC
    Inventor: Kenneth Wilson
  • Patent number: 9452996
    Abstract: The invention is directed to compounds of Formula I: wherein Z, X, J, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, colon cancer, stomach cancer, hairy cell leukemia and non-small lung carcinoma; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including arthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.
    Type: Grant
    Filed: October 30, 2015
    Date of Patent: September 27, 2016
    Assignee: Janssen Pharmaceutica NV
    Inventors: Carl R. Illig, Shelley K. Ballentine, Jinsheng Chen, Renee Louise Desjarlais, Sanath K. Meegalla, Mark Wall, Kenneth Wilson
  • Patent number: 9403804
    Abstract: The invention is directed to compounds of Formula I: wherein Z, X, J, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, prostate cancer, lung cancer, colon cancer, stomach cancer, hairy cell leukemia; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including rheumatoid arthritis, and other forms of inflammatory arthritis, osteoarthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.
    Type: Grant
    Filed: July 21, 2014
    Date of Patent: August 2, 2016
    Assignee: Janssen Pharmaceutica NV
    Inventors: Carl R. Illig, Shelley K. Ballentine, Jinsheng Chen, Renee Louise Desjarlais, Sanath K. Meegalla, Mark Wall, Kenneth Wilson
  • Patent number: 9394289
    Abstract: The invention is directed to compounds of Formula I: wherein Z, X, J, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, prostate cancer, lung cancer, colon cancer, stomach cancer, hairy cell leukemia; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including rheumatoid arthritis, and other forms of inflammatory arthritis, osteoarthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.
    Type: Grant
    Filed: September 9, 2014
    Date of Patent: July 19, 2016
    Assignee: Janssen Pharmaceutica NV
    Inventors: Carl R. Illig, Shelley K. Ballentine, Jinsheng Chen, Renee Louise Desjarlais, Sanath K. Meegalla, Mark Wall, Kenneth Wilson, Bruce E. Tomczuk
  • Publication number: 20160122334
    Abstract: The invention is directed to compounds of Formula I: wherein Z, X, J, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, prostate cancer, lung cancer, colon cancer, stomach cancer, hairy cell leukemia; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including rheumatoid arthritis, and other forms of inflammatory arthritis, osteoarthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.
    Type: Application
    Filed: January 14, 2016
    Publication date: May 5, 2016
    Inventors: Carl R. ILLIG, Jinsheng CHEN, Renee Louise DESJARLAIS, Kenneth WILSON
  • Patent number: 9322233
    Abstract: A downhole activation system within a tubular. The system includes an axially movable member; a first magnetic field source having a first field with a first axial orientation movable with the member. A second magnetic field source having a second field with an axial orientation different from the first orientation and separated from the first magnetic field source. The second field being magnetically repulsed by the first field; and, a biasing device urging the second magnetic field source towards the first magnetic field source; wherein movement of the first magnet via the member towards the second magnet moves the second magnet in a direction against the biasing device. A method of activating an activatable member in a downhole tubular.
    Type: Grant
    Filed: August 1, 2014
    Date of Patent: April 26, 2016
    Assignee: BAKER HUGHES INCORPORATED
    Inventor: Kenneth Wilson